跳转至内容
Merck
  • Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.

Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.

Nouvelle revue francaise d'hematologie (1993-02-01)
J L Binet
摘要

The review of Phase II trials in patients treated by Fludarabine phosphate (Fludara I.V) has been demonstrated to have unequivocal benefit for some patients with Chronic Lymphocytic Leukemia (CLL) non Hodgkin lymphoma and macroglobulinemia. Comparison of Fludara I.V with other treatment regimens is now studied in randomised protocols for B and C stages of CLL.

材料
货号
品牌
产品描述

Sigma-Aldrich
氟达拉滨
氟达拉滨, European Pharmacopoeia (EP) Reference Standard
氟达拉滨, European Pharmacopoeia (EP) Reference Standard